Article Details
Retrieved on: 2021-12-26 17:34:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
China-based CanSino Biologics Inc. announced on December 24, 2021, that The Lancet published its Phase III clinical trial results on the safety ...
Article found on: www.precisionvaccinations.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here